openPR Logo
Press release

Stent Graft Balloon Catheter Market to Reach US$ 1,000 Mn by 2022

08-22-2017 12:51 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

Stent Graft Balloon Catheter Market to Reach US$ 1,000 Mn by 2022

The global stent graft balloon catheter market will register a healthy expansion during 2017 to 2022. Revenues from the market are expected to surpass US$ 1,000 Mn by the end of 2022.

Usually utilized in bypass graft surgery as well as balloon angioplasty, stent graft balloon catheters prevent risks concerning occurrence of re-narrowing in patients undergoing angioplasty, and risks related to abrupt artery closure. Owing to these advantages offered by stent graft balloon catheters, their demand is witnessing a rise. A gradual evolution has been observed in the stent graft balloon catheter market, from the simple stents to modification of balloon stent catheters. Since recent past, there has been a surge in hospital admissions caused by increasing cases of atherosclerosis, and soaring prevalence of CAD – coronary artery disease globally. Numerous developments have been realized in technology of balloon catheters, along with the hike in healthcare expenditure. These factors are expected to augment growth of the market. In contrast, high prices of angioplasty procedures has become a problem for population across developing and underdeveloped economies. This might act as an impeding factor for the market growth.

Request For Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=149

Growth of the global stent graft balloon catheter market has been highly favored by the advent of drug eluting balloons. In addition, shifting preferences towards using balloons with drug delivery, and helping to deliver medications at local sites, has deemed them to be effective substitutes for administering drugs intravenously. Various new products developed are being approved for treatment of vascular diseases. For instance – recently, the FDA has approved use of expandable balloon stent graft introduced by the W.L. Gore & Associates to treat peripheral artery disease. Moreover, technology advancements in the stent graft balloon catheters, coupled with increasing awareness about angioplasty, and sophisticated healthcare infrastructure in developed economies are further poised to drive the market growth in the near future.

9 Key Estimations from Fact.MR’s Report on the Global Stent Graft Balloon Catheter Market

Based on raw material, sales of polyurethane for producing stent graft balloon catheters will register a steady expansion, while sales of nylon are estimated to register a sluggish growth through 2022.

Cardiac catheterization laboratories are anticipated to become the fastest growing end-users in the global stent graft balloon catheter market.

Ambulatory surgical centres are expected to be the least lucrative end-users of stent graft balloon catheters.

Request For Discount: https://www.factmr.com/connectus/sample?flag=D&rep_id=149

Hospitals will continue to be the largest end-user segment, with sales poised to reach nearly US$ 900 Mn by 2022-end.

Sales of stent graft balloon catheters for coronary artery disease indication are projected to account for over two-third share of the market over the forecast period, in terms of revenues.

Demand for stent graft balloon catheters from peripheral vascular disease indication segment will remain sluggish in the market.

Although, the market in Middle East & Africa (MEA) is expected to register a sluggish expansion, sales of stent graft balloon catheter in this region are estimated to gain an uptick by 2022-end.

Europe will continue to be the largest market for stent graft balloon catheter, with sales projected to exceed US$ 400 Mn in revenues by 2022-end.

Key players contributing to growth of the market include Meril Life Sciences Pvt. Ltd., Abbott Laboratories, Hexacath, Cardionovum GmbH, Jotech GmbH, MicroPort Scientific Corporation, Boston Scientific Corporation, Terumo Corporation, Cook Medical INC, B. Braun Melsungen AG, Cordis Corporation, and Medtronic Plc.

Browse Full Report: https://www.factmr.com/report/149/stent-graft-balloon-catheter-market

ABOUT US:
Fact.MR is focused on offering transformative intelligence that inspires breakthroughs and innovation. We believe that the right decisions at the opportune time are integral to achieve extraordinary success. We are here to help you with your strategic decision making.

CONTACT:
Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Phone: +353-1-6111-593
Email: sales@factmr.com
Website: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stent Graft Balloon Catheter Market to Reach US$ 1,000 Mn by 2022 here

News-ID: 679344 • Views:

More Releases from Fact.MR

Baby Bottle Market Expected to Surpass US$ 5.8 Billion by 2034 at 4.7% CAGR
Baby Bottle Market Expected to Surpass US$ 5.8 Billion by 2034 at 4.7% CAGR
According to a Fact.MR report, the global baby bottle market is expected to develop at a compound annual growth rate (CAGR) of 4.7%, from a valuation of US$ 3.7 billion in 2024 to US$ 5.8 billion by the end of 2034. The demand for them is expected to rise as more parents become aware of the benefits of bottle feeding infants in the early stages of life. Baby bottle sales are
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: Fact.MR Report
Bagless Vacuum Cleaners Market Is Predicted To Touch US$ 39.52 Billion By 2033: …
The global demand for bagless vacuum cleaners is forecasted to experience a compound annual growth rate (CAGR) of 8% from 2023 to 2033. Consequently, the market for bagless vacuum cleaners worldwide is anticipated to surge from a value of US$ 18.3 billion in 2023 to reach US$ 39.52 billion by the end of 2033. The Bagless Vacuum Cleaner Industry sales study offers a comprehensive analysis on diverse features including production
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact.MR Report
NFC Chips Are Predicted To Reach US$ 7.6 Billion At A CAGR Of 15% By 2033: Fact. …
The global NFC chip market is valued at US$ 1.9 billion in 2023 and is forecasted to surge at a CAGR of 15% to reach a market size of US$ 7.6 billion by the end of 2033. The NFC Chip Industry sales study offers a comprehensive analysis on diverse features including production capacities, NFC Chip demand, product developments, sales revenue generation and NFC Chip market outlook across the globe. market research
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Report
Canned Beans Market Is Anticipated To Reach US$ 15 Billion By 2033: Fact.MR Repo …
The global canned beans market is valued at US$ 5.65 billion in 2023 and is projected to reach US$ 15 billion by the end of 2033, expanding at a high-value CAGR of 10.3% from 2023 to 2033. The Canned Beans Industry sales study offers a comprehensive analysis on diverse features including production capacities, Canned Beans demand, product developments, sales revenue generation and Canned Beans market outlook across the globe. market research

All 5 Releases


More Releases for Stent

Gel Stent Market Will Generate Booming Growth Opportunities to 2032 | Clinical P …
The latest Global Gel Stent Market research report 2022 provides detailed information about the market overview, prevalent trends, demand, and recent developments impacting the market growth during the upcoming years. The Gel Stent market report also covers the size, share, potential growth, and industry strategy followed by prominent players. This report also includes profiles for major companies within the market. There is wide acceptance of Gel Stent across the buyers' segments and this has been driving the
Gel Stent Market To Offer Lucrative Growth Opportunities to 2032 | Clinical Phas …
The global Gel Stent market research report offers domain wherein 2020 is historic period, 2021 is the base year, and 2022 to 2032 is forecast period. The wide application portfolio of Gel Stent is one of factors driving the growth of domain worldwide. The global market is moderately competitive with a blend of global and regional players. The industry players invest significantly in R&D to enhance their offerings. The entire
Global Evar Stent Grafts Market, Global Evar Stent Grafts Industry, Covid-19 Imp …
The aortic-aneurysm is a swelling & dilation the wall of blood-vessel, in general an artery, owing to weakness or degeneration, which develops in the segment of artery wall. Endovascular-aneurysm-repair or EVAR contains the conveying of implant in the aneurysm through small-groin incisions with X-rays to guide the graft into place. EVAR is an ideal treatment option for the aortic aneurysm considering to its advantages over the open surgery. Some of
Airway Stent/Lung Stent Market Size, Share, Trends & Forecast 2019-2025
The airway stent/lung stent market is forecast to grow at a CAGR of 5.8% attributed to the increasing adoption of bronchial stents in the treatment of lung cancer and other chronic respiratory diseases. The airway invasion is common in the patient diagnosed with lung cancer. These patients may develop stridor, intractable cough, post obstructive, dyspnea, hemorrhage, pneumonia and intractable cough due to tracheobronchial tumor extension. The optimal management of patients
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Global Coronary Stent Grafts Market to Observe Strong Development during the For …
In the recent decades the number of myocardial revascularization procedures, incorporating coronary angioplasty, in chronic stable angina (CSA) patients has grown significantly. Irrespective of various innovations in coronary angioplasty techniques that require coronary stent grafts, recurrent angina post coronary angioplasty has become a frequent medical issue that many cardiologists in clinical practice have to face. The plight has turned so worse that over 30% of patients with prior revascularization still